Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

Epidemiology of Silent and Overt Strokes in Sickle Cell Disease

NCT03376893

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +16 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
View Trial Details
Active, Not Recruiting

Acalabrutinib, Venetoclax, and Obinutuzumab for Initial Therapy of CLL

NCT03580928

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
Locations
  • Stamford Hospital/Bennett Cancer Center Stamford, Connecticut, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Lifespan Cancer Institute Providence, Rhode Island, United States
View Trial Details
Active, Not Recruiting

Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries

NCT03657394

Conditions
Anemia, Anemia, Neonatal, Asphyxia Neonatorum, +20 more
Locations
  • KLE Academy of Higher Education and Research (Deemed-to-be-University) Jawaharlal Nehru Medical College Belagavi, Karnataka, India
  • Indira Gandhi Government Medical College & Hospital Nagpur, Maharashtra, India
  • Pimpri Chinchwad Municipal Corporation's Post-Graduate Institute, Yashwantrao Chavan Memorial Hospital Pune, Maharashtra, India
  • Government Medical College Chandrapur, MS, India
View Trial Details
Active, Not Recruiting

SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS

NCT06325748

Conditions
AML/MDS, Blastic Plasmacytoid Dendritic Cell Neoplasm, Blood Protein Disorders, +33 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • TriStar Bone Marrow Transplant Nashville, Tennessee, United States
View Trial Details

Related conditions